Agoracom Blog

@Novamind_Inc $ $NVMDF Weekly Roundup $ $MMED $ $ $CMPS $

Posted by AGORACOM-JC at 9:54 AM on Saturday, February 20th, 2021

A weekly summary of Novamind news and media

FEATURES February 19, 2021

Dr. Reid Robison on Our Purpose-Driven Mission to Help People who are Suffering

Agoracom interviewed our Chief Medical Officer about our latest expansions, the striking results from treatments, and what it takes to build infrastructure for psychedelic-assisted healthcare.

FEATURES February 18, 2021

Novamind Leading the Charge to Deliver Mental Health Alternatives

Psychedelic Invest published an article about the urgent need for innovative mental health treatments, and the companies working to meet that need.

View all media

Novamind Announces Symbol Change on OTC Market To “NVMDF”

February 19, 2021

View all press releases

Follow @novamind_inc on Instagram

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit

Tags: , , , ,

Comments are closed.